RX871024 reduces NO production but does not protect against pancreatic β-cell death induced by proinflammatory cytokines

Irina I. Zaitseva, Vladimir Sharoyko, Joachim Størling, Suad Efendic, Christopher Guerin, Thomas Mandrup-Poulsen, Pierluigi Nicotera, Per Olof Berggren, Sergei V. Zaitsev

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The imidazoline compound RX871024 reduces IL-1β-induced NO production thereby protecting against IL-1β-induced β-cell apoptosis. The aim of this study was to evaluate whether imidazolines RX871024 and efaroxan protect β-cells against death in the presence of a combination of the cytokines IL-1β, IFNγ, and TNFα. To address this issue, experiments involving different methods for detection of cell death, different concentrations of the cytokines, and a variety of conditions of preparation and culturing of ob/ob mouse islets and β-cells have been carried out. Thoroughly performed experiments have not been able to demonstrate a protective effect of RX871024 and efaroxan on β-cell death induced by the combination of cytokines. However, the inhibitory effect of RX871024 on NO production in ob/ob mouse islets and β-cells was still observed in the presence of all three cytokines and correlated with the decrease in p38 MAPK phosphorylation. Conversely, efaroxan did not affect cytokine-induced NO production. Our data indicate that a combination of pro-inflammatory cytokines IL-1β, IFNγ, and TNFα, conditions modelling those that take place in type 1 diabetes, induces pancreatic β-cell death that does not directly correlate with NO production and cannot be counteracted with imidazoline compounds.

Original languageEnglish
Pages (from-to)1121-1128
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume347
Issue number4
DOIs
StatePublished - Sep 8 2006
Externally publishedYes

Fingerprint

efaroxan
Cell death
Cell Death
Cytokines
Imidazolines
Interleukin-1
Islets of Langerhans
Phosphorylation
p38 Mitogen-Activated Protein Kinases
Medical problems
Type 1 Diabetes Mellitus
2-(2-imidazolin-2-yl)-1-phenyl-1H-indole
Experiments
Apoptosis

Keywords

  • Apoptosis
  • Cytokine
  • Imidazoline
  • Insulin
  • Islet of langerhans
  • MAPK
  • TUNEL labelling

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

RX871024 reduces NO production but does not protect against pancreatic β-cell death induced by proinflammatory cytokines. / Zaitseva, Irina I.; Sharoyko, Vladimir; Størling, Joachim; Efendic, Suad; Guerin, Christopher; Mandrup-Poulsen, Thomas; Nicotera, Pierluigi; Berggren, Per Olof; Zaitsev, Sergei V.

In: Biochemical and Biophysical Research Communications, Vol. 347, No. 4, 08.09.2006, p. 1121-1128.

Research output: Contribution to journalArticle

Zaitseva, II, Sharoyko, V, Størling, J, Efendic, S, Guerin, C, Mandrup-Poulsen, T, Nicotera, P, Berggren, PO & Zaitsev, SV 2006, 'RX871024 reduces NO production but does not protect against pancreatic β-cell death induced by proinflammatory cytokines', Biochemical and Biophysical Research Communications, vol. 347, no. 4, pp. 1121-1128. https://doi.org/10.1016/j.bbrc.2006.06.197
Zaitseva, Irina I. ; Sharoyko, Vladimir ; Størling, Joachim ; Efendic, Suad ; Guerin, Christopher ; Mandrup-Poulsen, Thomas ; Nicotera, Pierluigi ; Berggren, Per Olof ; Zaitsev, Sergei V. / RX871024 reduces NO production but does not protect against pancreatic β-cell death induced by proinflammatory cytokines. In: Biochemical and Biophysical Research Communications. 2006 ; Vol. 347, No. 4. pp. 1121-1128.
@article{d757d9452e0b4b6ea49540a3fcdd3828,
title = "RX871024 reduces NO production but does not protect against pancreatic β-cell death induced by proinflammatory cytokines",
abstract = "The imidazoline compound RX871024 reduces IL-1β-induced NO production thereby protecting against IL-1β-induced β-cell apoptosis. The aim of this study was to evaluate whether imidazolines RX871024 and efaroxan protect β-cells against death in the presence of a combination of the cytokines IL-1β, IFNγ, and TNFα. To address this issue, experiments involving different methods for detection of cell death, different concentrations of the cytokines, and a variety of conditions of preparation and culturing of ob/ob mouse islets and β-cells have been carried out. Thoroughly performed experiments have not been able to demonstrate a protective effect of RX871024 and efaroxan on β-cell death induced by the combination of cytokines. However, the inhibitory effect of RX871024 on NO production in ob/ob mouse islets and β-cells was still observed in the presence of all three cytokines and correlated with the decrease in p38 MAPK phosphorylation. Conversely, efaroxan did not affect cytokine-induced NO production. Our data indicate that a combination of pro-inflammatory cytokines IL-1β, IFNγ, and TNFα, conditions modelling those that take place in type 1 diabetes, induces pancreatic β-cell death that does not directly correlate with NO production and cannot be counteracted with imidazoline compounds.",
keywords = "Apoptosis, Cytokine, Imidazoline, Insulin, Islet of langerhans, MAPK, TUNEL labelling",
author = "Zaitseva, {Irina I.} and Vladimir Sharoyko and Joachim St{\o}rling and Suad Efendic and Christopher Guerin and Thomas Mandrup-Poulsen and Pierluigi Nicotera and Berggren, {Per Olof} and Zaitsev, {Sergei V.}",
year = "2006",
month = "9",
day = "8",
doi = "10.1016/j.bbrc.2006.06.197",
language = "English",
volume = "347",
pages = "1121--1128",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - RX871024 reduces NO production but does not protect against pancreatic β-cell death induced by proinflammatory cytokines

AU - Zaitseva, Irina I.

AU - Sharoyko, Vladimir

AU - Størling, Joachim

AU - Efendic, Suad

AU - Guerin, Christopher

AU - Mandrup-Poulsen, Thomas

AU - Nicotera, Pierluigi

AU - Berggren, Per Olof

AU - Zaitsev, Sergei V.

PY - 2006/9/8

Y1 - 2006/9/8

N2 - The imidazoline compound RX871024 reduces IL-1β-induced NO production thereby protecting against IL-1β-induced β-cell apoptosis. The aim of this study was to evaluate whether imidazolines RX871024 and efaroxan protect β-cells against death in the presence of a combination of the cytokines IL-1β, IFNγ, and TNFα. To address this issue, experiments involving different methods for detection of cell death, different concentrations of the cytokines, and a variety of conditions of preparation and culturing of ob/ob mouse islets and β-cells have been carried out. Thoroughly performed experiments have not been able to demonstrate a protective effect of RX871024 and efaroxan on β-cell death induced by the combination of cytokines. However, the inhibitory effect of RX871024 on NO production in ob/ob mouse islets and β-cells was still observed in the presence of all three cytokines and correlated with the decrease in p38 MAPK phosphorylation. Conversely, efaroxan did not affect cytokine-induced NO production. Our data indicate that a combination of pro-inflammatory cytokines IL-1β, IFNγ, and TNFα, conditions modelling those that take place in type 1 diabetes, induces pancreatic β-cell death that does not directly correlate with NO production and cannot be counteracted with imidazoline compounds.

AB - The imidazoline compound RX871024 reduces IL-1β-induced NO production thereby protecting against IL-1β-induced β-cell apoptosis. The aim of this study was to evaluate whether imidazolines RX871024 and efaroxan protect β-cells against death in the presence of a combination of the cytokines IL-1β, IFNγ, and TNFα. To address this issue, experiments involving different methods for detection of cell death, different concentrations of the cytokines, and a variety of conditions of preparation and culturing of ob/ob mouse islets and β-cells have been carried out. Thoroughly performed experiments have not been able to demonstrate a protective effect of RX871024 and efaroxan on β-cell death induced by the combination of cytokines. However, the inhibitory effect of RX871024 on NO production in ob/ob mouse islets and β-cells was still observed in the presence of all three cytokines and correlated with the decrease in p38 MAPK phosphorylation. Conversely, efaroxan did not affect cytokine-induced NO production. Our data indicate that a combination of pro-inflammatory cytokines IL-1β, IFNγ, and TNFα, conditions modelling those that take place in type 1 diabetes, induces pancreatic β-cell death that does not directly correlate with NO production and cannot be counteracted with imidazoline compounds.

KW - Apoptosis

KW - Cytokine

KW - Imidazoline

KW - Insulin

KW - Islet of langerhans

KW - MAPK

KW - TUNEL labelling

UR - http://www.scopus.com/inward/record.url?scp=33746343031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746343031&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2006.06.197

DO - 10.1016/j.bbrc.2006.06.197

M3 - Article

C2 - 16870144

AN - SCOPUS:33746343031

VL - 347

SP - 1121

EP - 1128

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -